This study suggests that combined inhibition of PI3K/AKT signaling and integrins can synergistically inhibit pancreatic cancer cell metastasis (Figures 5M, N), providing new insights for overcoming monotherapy resistance. This evidence concerns the gene AKT1 and pancreatic neoplasm.